“Targeted policies” aimed at improving the conditions for generic and biosimilar competition, removing barriers to market and increasing uptake and patient access have been put in motion by the European Commission as part of its Pharmaceutical Strategy for Europe announced today.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?